Free Account Opening + AMC Free Demat
Loading...
Shree Ganesh Remedies Rights Issue 2023 Detail
Issue Open February 13, 2023
Issue Close February 21, 2023
Issue Size (Shares) 0.08 Crores
Issue Size (Amount) ₹18.91 Crores
Issue Price ₹225 per Share
Listing At BSE

Shree Ganesh Remedies Rights Issue 2023 Date & Price FAQs

Shree Ganesh Remedies Rights Issue 2023 Timetable

Last Date for credit of Rights EntitlementsFebruary 15, 2023
Last Date for renunciation of Rights EntitlementsFebruary 15, 2023
Issue Opening DateFebruary 13, 2023
Issue Closing DateFebruary 21, 2023
Allotment DateMarch 1, 2023
Shares Credit DateMarch 3, 2023
Listing DateMarch 8, 2023

Shree Ganesh Remedies Rights Issue 2023 price is set at ₹225 per Share. The Shree Ganesh Remedies Rights Issue 2023 opens on February 13, 2023, and closes on February 21, 2023, for the subscription.

The allotment of Shree Ganesh Remedies Rights Issue 2023 is expected to happen on or about March 1, 2023 as per the issue schedule.

Shree Ganesh Remedies Rights Issue 2023 expected to list on or around March 8, 2023.

The credit of Shree Ganesh Remedies Rights Issue 2023 in Demat account is expected on or about March 3, 2023 as per the issue schedule.

The Company intends to utilize the Net Proceeds from the Issue towards the funding of the following objects:

  1. Part repayment or prepayment of unsecured loans availed from the Promoters and from the member of the Promoter Group
  2. Meeting Working Capital Requirements; and
  3. General corporate purposes.

It is difficult to say at what price Shree Ganesh Remedies Rights Issue 2023 shares will list. The price depends on the demand and supply of company's shares on the day of listing.

Sorry, we do not provide rights issue's recommendations. But we share a lot of information about Shree Ganesh Remedies Rights Issue 2023 which could help you with questions like Shree Ganesh Remedies Rights Issue 2023 buy or not? Consider reading Shree Ganesh Remedies Rights Issue 2023 reviews and analysis from experts posted on rights issue detail page.